𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Type II Estrogen-Binding Sites in Human Ovarian Cancer: Correlation with Estrogen, Progesterone, and Epidermal Growth Factor Receptor

✍ Scribed by Gabriella Ferrandina; Giovanni Scambia; Pierluigi Benedetti Panici; Franco Oreste Ranelletti; Rosa De Vincenzo; Mauro Piantelli; Mariagrazia Distefano; Arnaldo Capelli; Salvatore Mancuso

Book ID
115615809
Publisher
Elsevier Science
Year
1993
Tongue
English
Weight
293 KB
Volume
49
Category
Article
ISSN
0090-8258

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Quercetin induces type-II estrogen-bindi
Quercetin induces type-II estrogen-binding sites in estrogen-receptor-negative (MDA-MB231) and estrogen-receptor-positive (MCF-7) human breast-cancer cell lines
✍ G. Scambia; S. Mancuso; P. Benedetti Panici; R. De Vincenzo; G. Ferrandina; G. B 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 French ⚖ 536 KB

## Abstract We show that flavonoids positively regulate type‐II estrogen‐binding site (type‐ll EBS) levels both in MCF‐7 (ER‐positive) and in MDA‐MB231 (ER‐negative) breast‐cancer cells. Type‐ll EBS were measured by a whole‐cell assay at 4°C for 2.5 hr using [^3^H]‐estradiol as tracer. In both cell

Expression of estrogen, progesterone and
Expression of estrogen, progesterone and epidermal growth factor receptors in primary and metastatic breast cancer
✍ Ton van Agthoven; Mieke Timmermans; Lambert C. J. Dorssers; Sonja C. Henzen-Logm 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 473 KB 👁 2 views

The prognostic value of epidermal growth factor receptor (EGFR) expression and its biological role in estrogen receptorpositive (ER+) and ER-negative (ER-) primary breast cancer is controversial. In this study, distributions of ER, progesterone receptor and EGFR have been established using immunohis

Methyl-p-Hydroxyphenyllactate-esterase a
Methyl-p-Hydroxyphenyllactate-esterase activity and type-II estrogen-binding sites in ovarian cancer: Correlation with biological and clinico-pathological parameters
✍ Franco O. Ranelletti; Giovanni Scambia; Pierluigi Benedetti Panici; Mauro Piante 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 611 KB

We examined the levels of activity of methyl-p-hydroxyphenyllactate esterase (MeHPLA-ase) and cytosolic Type-ll-estrogenbinding sites (Type-ll EBS) in 61 and 71 cases, respectively, of primary ovarian cancer. MeHPlA-ase activity and Type-ll EBS were seen to by asymmetrically distributed, in that lev